Medical Education Library

Exploring the Role of Modified-Release Doxycycline in Rosacea


A Journal Scan supplement to Family Practice News®. This supplement was sponsored by Galderma Laboratories, L.P.


  • Introduction - Exploring the Role of Modified-Release
  • Doxycycline in Rosacea
  • Comparing Antimicrobial and Anti-Inflammatory Doses of Oral Doxycycline in the Treatment of Rosacea
  • Impact of Antibiotic Resistance on Dermatologic Practice
  • The Effects of Modified-Release Doxycycline on Quality of Life
  • Combining Anti-Inflammatory–Dose Doxycycline With Topical Metronidazole

To view the supplement, click the image above.

Faculty/Faculty Disclosure

Brian Berman, MD, PhD
Voluntary Professor of Dermatology and Cutaneous Surgery
University of Miami, Miller School of Medicine Co-Director
Center for Clinical and Cosmetic Research, Skin & Cancer Associates, LLP, Aventura, FL

Dr Berman has received funding for clinical grants from, is an investigator for, and is a consultant to, Galderma Laboratories, L.P.

Copyright (c) 2012 by Elsevier Inc.

Next Article: